Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma

3 Oct 2023

Abstract excerpt

BACKGROUND: Recent studies have indicated that epigenetic alterations contribute significantly to lymphoma pathogenesis. A type of epigenetic regulation known as histone acetylation plays a crucial role in transcriptional regulation in eukaryotic cells. Specifically, a significant effect of histone acetylation modifications on the abnormal progression and microenvironment of diffuse large B-cell lymphoma (DLBCL)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Histone Deacetylase Inhibitors Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37789275
DOI: 10.1186/s12885-023-11401-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphomaPMID 37789275Read ↗

Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor MicroenvironmentSemantic proximity Read ↗

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphomaSemantic proximity Read ↗

Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphomaSemantic proximity Read ↗

The PVT1, HULC, and HOTTIP expression changes due to treatment in Diffuse Large B-cell lymphomaSemantic proximity Read ↗

Histone Modifications and Their Targeting in Lymphoid MalignanciesSemantic proximity Read ↗

Immunogenomic-based analysis of hierarchical clustering of diffuse large cell lymphomaSemantic proximity Read ↗

CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axisSemantic proximity Read ↗

Acetylation in Tumor Immune Evasion RegulationSemantic proximity Read ↗

The multifaceted role of lysine acetylation in cancer: prognostic biomarker and therapeutic targetSemantic proximity Read ↗

The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and ProgressionSemantic proximity Read ↗

Comprehensive analysis of histone acetylation‐related genes in glioblastoma and lower‐grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.